NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced this week that it has completed its $4.2 billion acquisition of electron microscopy company FEI. Thermo Fisher paid $107.50 per share in cash. FEI will become part of Thermo Fisher's analytical instruments business unit.


Agilent Technologies said this week that its board has approved a quarterly dividend of $.12 per share of common stock, to be paid on Oct. 26, to all shareholders of record as of Oct. 4.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.